Effect of diagnosis related groups implementation on the intensive care unit of a Swiss tertiary hospital: a cohort study by Chok, Lionel et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2018
Effect of diagnosis related groups implementation on the intensive care unit
of a Swiss tertiary hospital: a cohort study
Chok, Lionel; Bachli, Esther B; Steiger, Peter; Bettex, Dominique; Cottini, Silvia R; Keller, Emanuela;
Maggiorini, Marco; Schuepbach, Reto A
DOI: https://doi.org/10.1186/s12913-018-2869-4
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: https://doi.org/10.5167/uzh-158909
Journal Article
Published Version
 
 
The following work is licensed under a Creative Commons: Public Domain Dedication: CC0 1.0 Universal
(CC0 1.0) License.
Originally published at:
Chok, Lionel; Bachli, Esther B; Steiger, Peter; Bettex, Dominique; Cottini, Silvia R; Keller, Emanuela;
Maggiorini, Marco; Schuepbach, Reto A (2018). Effect of diagnosis related groups implementation on the
intensive care unit of a Swiss tertiary hospital: a cohort study. BMC Health Services Research, 18:84.
DOI: https://doi.org/10.1186/s12913-018-2869-4
RESEARCH ARTICLE Open Access
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of a Swiss tertiary hospital: a cohort study
Lionel Chok1,2, Esther B. Bachli2, Peter Steiger1, Dominique Bettex1, Silvia R. Cottini1, Emanuela Keller1,
Marco Maggiorini1 and Reto A. Schuepbach1*
Abstract
Background: In 2013 the Swiss Diagnosis Related Groups ((Swiss)-DRG) was implemented in Intensive Care Units (ICU).
Its impact on hospitalizations has not yet been examined. We compared the number of ICU admissions, according to
clinical severity and referring institution, and screened whether implementation of Swiss-DRG affected admission policy,
ICU length-of-stay (ICU-LOS) or ICU mortality.
Methods: Retrospective, single centre, cohort study conducted at the University Hospital Zurich, Switzerland between
January 2009 and end of September 2013. Demographic and clinical data was retrieved from a quality assurance database.
Results: Admissions (n= 17,231) before the introduction of Swiss-DRG were used to model expected admissions after DRG,
and then compared to the observed admissions. Forecasting matched observations in patients with a high clinical severity
admitted from internal units and external hospitals (admitted / predicted: 709 / 703, [95% Confidence Interval (CI), 658–748]
and 302 / 332, [95% CI, 269–365] respectively). In patients with low severity of disease, in-house admissions became more
frequent than expected and external admission were less frequent (admitted / predicted: 1972 / 1910, [95% CI, 1898–1940]
and 436 / 518, [95% CI, 482–554] respectively). Various mechanisms related to Swiss-DRG may have led to these changes.
DRG could not be linked to significant changes in regard to ICU-LOS and ICU mortality.
Conclusions: DRG introduction had not affected ICU admissions policy, except for an increase of in-house patients with a
low clinical severity of disease. DRG had neither affected ICU mortality nor ICU-LOS.
Keywords: Diagnosis related groups, DRG, ICU admissions, Epidemiology, Switzerland
Background
The Swiss health care system was rated second best in a
recent overall ranking [1]. However, it is in seventh place
as one of the most costly, consuming over 10.7% of the
Swiss gross national product [2]. Since costs for hospi-
talized patients kept growing by 3% yearly since 1995 [2,
3], transparency of health care costs and activity, as well
as improved efficiency, have become necessary. As a
potential remedy, the diagnosis related group (DRG)
system was adopted from Germany and implemented in
acute care in 2012 and intensive care units on January
1st 2013 [4–7]. Swiss-DRG regulates reimbursement of
health care providers. The DRG system assigns patients
to an individual DRG (group) based on: the patient’s
epidemiological information, diagnosis, clinical features
and procedures [8]. Patients in an individual DRG
(group) show a similar course of disease, comparable
length of (hospital) stay (LOS) and comparable require-
ment for treatment. Thus, expenditures should also be
comparable [9–11], allowing linkage of a specific DRG
(group) to reimbursement. The United States of America
first adopted this system in 1984 followed by most European
and developed countries [10, 12–14].
Aiming at improving efficiency, Swiss-DRG defines an
optimal LOS for a given clinical condition (DRG group).
Prolonged LOS assumes that the caregiver was inefficient,
and shortened LOS that services were incomplete. Thus,
the DRG system dictates a reduced daily reimbursement
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rate for out of range LOS. To avoid this mechanism, care-
givers might discharge or transfer economically unprofit-
able patients to ambulant care or services provided by
unrelated hospitals, ultimately increasing resource con-
sumption and readmission rates [10, 15, 16]. For example,
in France such DRG related shifts between private and
public institutions, and towards ambulatory services, have
been well documented for obstetrical patients [17]. In the
United Kingdom DRG resulted in the admission of
patients in need of low complexity surgeries to private
clinics, but admissions for more complex cases to public
services [18]. In contrast, in Germany no such side effects
have been linked to the DRG system [19], potentially due
to specific design features.
Although causality has not yet been established, these
examples illustrate the unintended phenomenon of
selection of profitable cases, and changes in patient flow
between acute care units observed after DRG implemen-
tation [10]. The absence of a risk adjustment in the
Swiss-DRG system may encourage non-tertiary hospitals
to engage in risk selection by admitting low, rather than
high-risk, patients for elective interventions [20]. The
Swiss DRG system compensates somewhat for certain
therapeutic complexities such as prolonged ventilation
or renal replacement therapy. However, coverage may be
insufficient in high cost patients as well as in patients
requiring ICU care, but not DRG reimbursed ventilation
or renal replacement therapy. Our hospital’s authorities
did not request any change in ICU admission policy
after Swiss-DRG introduction at our institution. Never-
theless, unintended mechanisms, could have led to
changes in number and type of admission. A shift of po-
tentially unprofitable patients from the private to the
public sector, or from secondary to tertiary hospitals, (as
was reported for obstetrical patients [17]) could also
affect ICU admissions, as these patients often require
short post intervention ICU stay. Alternatively, financial
pressure could reduce the availability of free ICU beds
and redirect patients with a low burden of disease to the
ward, and patients with minimal survival potential
towards palliative care and away from the ICU [21].
To date, no data is available, to our knowledge, on how
DRG affects ICU admission policies and ICU outcomes.
In order to analyse how the introduction of the Swiss-
DRG system affects ICU admission policies, we retrospect-
ively analysed the number of admissions, ICU-LOS, and
mortality in ICUs of a tertiary Swiss University Hospital.
The primary aim was to assess the amount of ICU
admissions of in and out patients during the pre-
DRG period (2009 to 2012) and to compare admis-
sion policies before and after the implementation of
Swiss-DRG on January 1st 2013. We further investi-
gated whether the Swiss-DRG affected ICU-LOS and
ICU mortality.
Methods
Study design
This retrospective, single-centre, observational trial com-
plies with the current version of the Declaration of Helsinki
and the national legal and regulatory requirements. It has
been approved by the Canton Ethics Committee (Kantonale
Ethikkommission Zurich, Switzerland, KEK-ZH-Nr. 2014–
0452). This study was conducted at the University Hospital
Zurich (UniversitätsSpital Zurich, Switzerland; USZ), a
Swiss, tertiary care, referral, teaching hospital. This 860 bed
hospital is Switzerland’s largest institution in terms of
annual admissions and delivers health care services
for over 1.4 million inhabitants in and around the
Canton of Zurich [22, 23].
Study population
All patients hospitalised in ICUs in the USZ between
January 1st 2009 and December 31th 2013 were in-
cluded. In addition to the implementation of Swiss-DRG
on January 1st 2013, ICU admission policies were also
affected by the inauguration of a large intermediate care
unit (IMC) in October 2013. Therefore, all patients
admitted to the ICU after the IMC was established were
excluded from analysis (Additional file 1: Figure S1).
Patients admitted during the period October to December
of the years 2009–2012 were also excluded to avoid poten-
tial seasonal bias.
Data collection
Demographic data on patients admitted to ICUs are rou-
tinely recorded for quality control and mandatory data
reporting to federal institutions. Since January 1st 2009,
the treating physicians and nurses have been trained to
accurately record and enter patients’ characteristics such
as vital parameters into an electronic system (KISIM™,
Cistec®, Switzerland). The data entered is controlled by
the attending physician followed by a final approval by
the clinical manager. From this data, an anonymized
subset of data was extracted containing demographics
and clinical information. It contained (i) gender, (ii) age
in years (no date of birth), (iii) ICU-LOS, (iv) clinical
gravity at the time of admission defined by the simplified
acute physiology score (SAPS II Score [24]), (v) eventual
occurrence of death during ICU stay, (vi) origin of the
patient (in-patient or external patient i.e. patients first
treated by a hospital other than the USZ).
Study objectives
All primary endpoints have been predetermined and
submitted to the Canton Ethics Committee before data
extraction and analysis. The primary objective was to
evaluate whether the number of patients with severe
disease admitted from external hospitals increased sig-
nificantly after the introduction of the DRG system. To
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dichotomize ICU patients into very sick and less sick
individuals we used the simplified acute physiology score
(SAPS II [24]) at a cut off of 40 [25–29].
Secondary outcomes included the analysis of the
severity-adjusted ICU-LOS and severity-adjusted ICU
mortality (occurrence of death during ICU stay) before
and after introduction of the Swiss-DRG. For this
purpose, data was stratified by using the SAPS II admis-
sion score in order to divide the population into groups
with similar characteristics.
Data analysis and statistics
Datasets were analysed using the NCSS 2007 (NCSS
Statistical Software, Kaysville, UT, USA), SPSS 22 (SPSS
Inc., Chicago, IL, USA) and StataCorp 2017 (StataCorp,
Stata Statistical Software: Release 15. College Station,
TX: StataCorp LLC, USA) software packages. These
were used together with Excel and Publisher (Microsoft
Office 2010, Microsoft Corporation, Redmond, WA,
USA) for data editing and presentation. There was no
missing data. Patient characteristics were represented
with descriptive statistics. The heterogeneity between
the groups was assessed using Chi-square and Kruskal-
Wallis tests.
In order to be able to examine whether implementa-
tion of the Swiss-DRG affected patient demographics,
we compared ICU admissions after DRG implementa-
tion to admissions forecasted based on data recorded
between 2009 and 2012. Forecasting of time series were
used, based on an exponential smoothing model (NCSS
software), which allowed for calculation of expected
admissions with 95% Confidence Intervals (CI) [30, 31].
Exponential smoothing has been described as a reliable
method for forecasting of health care time series [31].
The weighting parameter (α) of 0.3 resulted in the smal-
lest mean of the squared errors and was therefore used.
Using this model, we assumed that the evolution of med-
ical sciences and the health care system was continuous
throughout the whole study period and was not subject to
major structural, financial, or political changes other than
DRG implementation. Given the short time series available,
we also used a Poisson regression model (SPSS Inc.) and a
linear regression analysis based on forecasts with Newey-
West standard errors (Lag 1) (StataCorp) to test the robust-
ness of conclusions drawn by the exponential smoothing
model. The Poisson regression model adjusts for the bino-
mial variable DRG year/no-DRG year (logarithmic link
function: Log (Y) = β0 + β1X1 + β2X2, Y being the response
variable ‘count of admissions’, X1 and X2 the explanatory
variables ‘year of admission’ and ‘DRG status’ respect-
ively, β 0 the intercept, β 1 and β 2 the regression co-
efficient of the first and second variable, respectively). As
a third model to test for changes upon DRG implementa-
tion, we conducted sensitivity analyses using forecasts
with Newey-West standard errors (Lag 1) using Statistical
Software Stata 15.0 (StataCorp, College Station, TX: Stata-
Corp LLC, USA). Previous studies assessing ICU patients
described central values of dispersion of the SAPS II score
(mean and/or median) being around 40 [25–29]. We thus
defined patients having a SAPS II < 40 as cases with low
clinical severity at ICU admission, and those with a SAPS
II ≥ 40 as high severity cases.
In accordance to previous studies, we stratified patients
by SAPS II (a score describing the severity of disease) to
compare mortality between groups [26, 29, 32, 33].
Continuous secondary outcomes were analysed by using
the least squares linear regression analysis if data was
normally distributed. For non-normally distributed data, we
used the nonparametric bivariate Spearman’s rank correl-
ation. To test for trends by regression methods we entered
SAPS strata into the model as a continuous variable. Re-
sults were considered significant at P-values of < 0.05 or if
values were outside the 95% CI.
For comparisons of groups of continuous, non-
normally distributed variables, we used the nonparamet-
ric Kruskal-Wallis and Man-Whitney tests and paramet-
ric one-way analysis of variance (ANOVA) and Dunnett
t-tests. Binomial data (dichotomous outcomes, categor-
ical variable) was analysed with the Chi-square test or
Fisher’s exact test when cells had an expected frequency
of > 5 and differences between the groups were weighted
by the variance analysis.
Results
Characteristics of the population
Between January 1st 2009 and December 31, 2013, a total
of 23′107 patients were admitted to the ICUs of our insti-
tution. From these, admissions occurring October to
December were removed from analysis (n = 5876) in order
to prevent bias caused by structural changes (inauguration
of a 30 bed IMC in October 2013) and seasonal bias
(Additional file 1: Figure S1). Consequently, 17,231 pa-
tients entered analysis (Table 1). Patients were stratified
according to the year of admission, the type of admission
(in-house versus external), and the clinical severity of
disease (SAPS II).
Admissions stratified by origin and clinical gravity of
disease
In order to test whether Swiss-DRG affected admission
policy to ICUs in our institution we used a forecasting
model. Admissions observed between 2009 and 2012
were entered into an exponential smoothing model to
forecast the number of patients expected for admission
in 2013 (Fig. 1). Admissions observed in 2013 were con-
sidered to have been significantly affected by DRG if the
number of observed admissions was outside the 95% CI
of the admissions predicted by the forecasting model.
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We observed significantly more in-house admissions of
patients with a low SAPS II score (SAPS II ≥ 40;
observed count 1972, 95% CI of predicted count 1898–
1940; Fig. 1a) than predicted, and fewer admissions than
predicted of patients form external hospitals with a
SAPS II < 40 (observed count 436, 95% CI of predicted
count 482–554; Fig. 1c). An alternative forecast model
based on regression analysis with Newey-West standard
errors supported all conclusions obtained by the expo-
nential smoothing model (Additional file 1: Figure S2).
a
c
b
d
Fig. 1 DRG affected admissions of patient with a low burden of disease. Patients were stratified by the year of admission, the origin of admission
(in-house (a, b); from external hospitals (c, d)) and clinical severity at admission (SAPS II score < 40 (a, c); SAPS ≥40 (b, d)). Observed admissions in 2013
(x) are considered significantly affected by DRG if outside the 95% CI (whisker) of predicted admissions for 2013 (-) based admissions observed 2009 to
2012 (•). Forecasted and observed admissions were 1919 (95% CI: 1898–1940) and 1972 in (a), 703 (95% CI: 658–748) and 709 in (b), 518
(95% CI: 482–554) and 436 in (c) and 332 (95% CI: 269–395) and 302 respectively in (d)
Table 1 Baseline characteristics according to the year of admission
Year of admission All 2009 2010 2011 2012 2013
Demographics
Nbr. of Patients (% of total population) 17,231 3450 (20) 3498 (20.3) 3437 (19.9) 3427 (19.9) 3419 (19.8)
Age, median (IQR) 61 (47–72) 61 (46–71.25) 61 (47–71) 62 (48–72) 62 (49–73) 61 (48–71)
Male (%) 10,729 (62.3) 2128 (61.7) 2133 (61) 2158 (62.8) 2132 (62.2) 2178 (63.7)
In-house and external admission
In-house admissions (%) 13,492 (78.3) 2761 (80) 2744 (78.4) 2668 (77.6) 2638 (77) 2681 (78.4)
External admissions (%) 3739 (21.7) 689 (20) 754 (21.6) 769 (22.4) 789 (23) 738 (21.6)
SAPS II Score < 40 and ≥40
Patients with SAPS II < 40 (%) 13,058 (75.8) 2843 (82.4) 2651 (75.8) 2619 (76.2) 2537 (74) 2408 (70.4)
Patients with SAPS II≥ 40 (%) 4173 (24.2) 607 (17.6) 847 (24.2) 818 (23.8) 890 (26) 1011 (29.6)
In-house and external admission according to SAPS II Score
In-house patients with SAPS II < 40 (%) 10,590 (61.5) 2317 (67.2) 2180 (62.3) 2111 (61.4) 2010 (58.7) 1972 (57.7)
In-house patients with SAPS II ≥ 40 (%) 2902 (16.8) 444 (12.9) 564 (16.1) 557 (16.2) 628 (18.3) 709 (20.7)
External patients with SAPS II < 40 (%) 2468 (14.3) 526 (15.2) 471 (13.5) 508 (14.8) 527 (15.4) 436 (12.8)
External patients with SAPS II ≥ 40 (%) 1217 (7.4) 163 (4.7) 283 (8.1) 261 (7.6) 262 (7.6) 302 (8.8)
Chok et al. BMC Health Services Research  (2018) 18:84 Page 4 of 10
In line with the forecasting models, a Poisson regression
model supported Swiss-DRG-influenced reduction of
patients admitted with a SAPS II < 40 from external
hospitals (Additional file 1: Table S1).
Notably, over the observation period the amount of
very sick patients (SAPS II ≥ 40) generally increased,
regardless of the admission type (internal or external)
(Additional file 1: Table S2).
Correlation between clinical gravity and ICU-LOS
Next, we addressed whether introduction of Swiss-DRG
affected ICU-LOS. We found that ICU-LOS was not
significantly different before and after DRG implementa-
tion (Fig. 2a). As we observed an increase in the number
of very sick patients over time (Additional file 1: Table
S2), we tested whether the severity of disease (SAPS II)
affects ICU- LOS (Fig. 2b). We found median ICU-LOS
to increase up to a SAPS II of 69, but to decrease with
SAPS II higher than 70. As a result of this bell-shaped
pattern, Spearman’s rank correlation coefficient (rs) only
weakly correlated SAPS II and ICU-LOS (rs = 0.37;
Fig. 2b). This holds true for correlating SAPS and ICU-
LOS for individual years, as well as for the whole study
period (Additional file 1: Table S3). Using Fisher’s z trans-
formation, we found the SAPS II correlated significantly
stronger with the ICU-LOS in 2013 (rs = 0.41) than in
2009 (rs = 0.26), potentially indicating that disease severity
gained influence on ICU-LOS over the years.
Median LOS was highest in patients with a SAPS II of
around 70 and strata correlation revealed a positive SAPS
II to LOS correlation up to a SAPS II of 69 (rs = 0.39) but
a negative correlation for sicker patients (rs = − 0.30)
(Table 2).
We hypothesized that the bell-shaped relation between
ICU-LOS and disease severity (SAPS II) could be ex-
plained by two factors driving short ICU-LOS: low burden
of disease (low SAPS II) in ICU survivors, and high
burden of diseases (high SAPS II) in ICU fatalities. To test
for this, we stratified our study population into ICU survi-
vors and ICU fatalities. In ICU survivors, the Spearman’s
a b
c d
Fig. 2 Relation between the clinical severity of disease at admission (SAPS II) and the ICU LOS. a Evolution of ICU LOS between 2009 and 2013.
Comparison between the years (One-Way ANOVA) and to 2013 (Dunnett t-tests) n.s. b ICU LOS stratified by SAPS II and year of admission. ICU
LOS in survivors (c) and no survivors (d) stratified by the year of admission and the clinical severity at admission (SAPS II Score)
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rank correlation positively correlated SAPS II and ICU-
LOS (rs = 0.40, P < 0.01) (Fig. 2c). This holds true for the
whole study population as well as patients stratified by
year, with the correlation being strongest in 2013
(Additional file 1: Table S4).
Inversely, in non-survivors the SAPS II and the ICU-
LOS correlated negatively (rs = − 0.40, P < 0.01) (Fig. 2d).
This is again true for individual years as well as for the
whole study population, with the correlation being stron-
gest in 2013 (rs = − 0.46) (Additional file 1: Table S4).
ICU mortality before and after DRG introduction
Next, we addressed whether mortality changed over the
years and especially in 2013, the year of Swiss-DRG intro-
duction. Since the severity of disease increased over the
study period (Additional file 1: Table S2) we not only
stratified the study population by the year of admission,
but also by severity of disease. In order to apply a Pearson
Chi-square test to our data set, we needed to pool the few
patients with low burden of disease (SAPS 0–19) as well
as very sick patients (SAPS 90–129), while all others were
grouped by increments of 10 SAPS II points (Fig. 3a).
Overall, mortality remained stable over the period
analysed (Fig. 3b). However, there was a significant
excess mortality in 2009 in patients with low burden of
disease (SAPS II < 50). Although not significant, mortal-
ity was lowest in 5 of the strata in 2013, the year of
Swiss-DRG introduction, not consistent with Swiss-DRG
driving ICU mortality.
Discussion
This study analysed the effect of the Swiss-DRG intro-
duction on the number of admissions, the clinical grav-
ity, the length-of-stay, and the mortality of patients
admitted to a referral University hospital. We only
detected minor effects of Swiss-DRG, especially on admis-
sion policies. For example, an increase of in-patients with
a low clinical severity of disease, but fewer admissions of
such patients from external hospitals (Fig. 1) were ob-
served. The movement of patient populations are poten-
tially linked, as bed availability in ICU is limited and the
demand high. Importantly, other than a shift in admission
policies, DRG did not affect ICU-LOS or mortality; in
contrast, there was a trend towards reduced mortality
after implementation of Swiss-DRG (Fig. 3).
Previous studies have linked DRG implementation to
clinical outcomes such as LOS, mortality, quality of care,
and patient satisfaction [10]. Whether our finding of
reduced admissions of patients with low burden of dis-
ease from external hospitals (Fig. 1c) can be attributed
to the Swiss-DRG system remains controversial. Shifts of
low risk patients away from public referral centres have
been reported [18]. However, the German DRG system
which was used as a foundation for the Swiss-DRG, was
reported to prevent such shifts [19].
The increase of in-house ICU admissions with low
SAPS II score remains to be clarified (Fig. 1a). Firstly,
risk selection by health care providers after moving to
DRG-based reimbursement cannot fully be excluded. Of
note, SAPS II score does not fully address all patients’
diagnoses, as relevant comorbidities such as diabetes
mellitus or chronic obstructive pulmonary disease are
not captured by this score. Further studies are needed to
address whether the referral of patients with comorbidi-
ties (not captured by SAPS II) to tertiary public hospitals
for procedures or diagnostics explains the increase of
internal admissions with low SAPS II. Hence, one is
tempted to speculate that under Swiss-DRG admission
of high-risk, low profit cases after interventions or pro-
cedures increased in our tertiary hospital.
Table 2 The length of stay increased together with the clinical severity up to a SAPS II score of 69 and then decreases for even
higher SPAS II scores
Year of admission SAPS strata 1 to 7 (SAPS ≤69) SAPS strata 8 to 11 (SAPS > 69)
Correlation coefficient (rs) Independent correlation
with 2013, P value 1
Correlation coefficient (rs) Independent correlation
with 2013, P value 1
All 0.39 ** −0.30 **
2009 0.28 ** < 0.05 2 −0.37 ** NS
2010 0.43 ** NS −0.31 ** NS
2011 0.42 ** NS −0.39 ** NS
2012 0.42 ** NS −0.21 ** NS
2013 0.42 ** −0.30 **
Patients were stratified by the year of admission and the clinical severity at admission (SAPS II score ≤ 69, SAPS II score > 69). The correlation of the SAPS II score
and ICU LOS was considered significant if the P value was < 0.05 (*) using Spearman’s rank correlation. The correlation in 2013 was considered significantly
affected by DRG if the independent correlation with the pre-DRG years was above 1.96 using Fisher’s z transformation
NS nonsignificant
**P value < 0.01
1The independent correlation with 2013 was calculated using Fisher’s z transformation. A P value < 0.05 meaning a significant difference between the correlations
(the null hypothesis of equal correlation being rejected)
2The relationship between the SAPS and the LOS is significantly stronger in 2013 (r = 0.419) than in 2009 (r = 0.275)
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Hypothetically, due to the overtime increasing ICU
bed constraints, the observed reduction of external refer-
rals may also have led to the increase of in-house admis-
sions by freeing beds for these patients.
Uncontrolled admissions, such as referrals from the
emergency room or from non-ICUs units, however, are less
susceptible to influence by a DRG-based remuneration.
Indeed no decrease in in-house admissions was observed.
Over the 5-year study period, we identified a constant
increase in admissions of patients with a high clinical
severity (Fig. 1b, d) which was not further accentuated
by Swiss-DRG implementation. This clearly shows that
financial incentives independent of Swiss-DRG imple-
mentation optimized ICU admission policies. Increas-
ingly non-ICU dependent patients were referred to
cheaper institutions such as IMCs. Although we did not
observe Swiss-DRG-related optimization, it may well
occur with delay. Since the end of 2013, we have ob-
served a massive decrease in ICU admissions of patients
with a low burden of disease (not shown). We are not
able to analyse whether this was a delayed effect of
DRG. Since after October 2013 a large and continuous
increase in IMC bed availability occurred in our institu-
tion, which could possibly explain our observations.
a
b
Fig. 3 DRG did not increase the ICU mortality. a Intensive care unit mortality according to the year of admission and stratified by the clinical
severity at admission (SAPS II score). b Mean residuals of Chi-square test assessing independency of ICU mortality and years 2009 to 2013, strati-
fied by the clinical severity at admission (SAPS II score); asterisk refers to significant mortality difference with the other years. P < 0.5 (*), < 0.01
(**) < 0.001 (***)
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Since specialized treatments are centralized in tertiary
hospitals, changes in in-house or external admissions of
patients with high severity of disease are unlikely to
occur as a result of DRG implementation.
In Swiss acute care units LOS decreased continuously
from 9.1 to 6.7 days during the previous decade, independ-
ent of DRG [2]. Thus optimisation already occurred long
before Swiss-DRG was introduced. Whether DRG further
reduces LOS and potentially ICU-LOS is controversial. A
Swiss multicenter post-hoc study outside the ICU setting
linked Swiss-DRG to shorter LOS [34], whereas two subse-
quent prospective analyses could not confirm optimisation
[35, 36]. Similarly, in Germany, DRG had no detectable
effect on LOS [19, 37]. We were also unable to directly link
Swiss-DRG to ICU-LOS. Explanations included: (i) there is
no such link, or (ii) the link has been obscured by many
other influences and thus there is a lack of (statistical)
power in our study. We found that variables affecting ICU-
LOS included the burden of disease and mortality which, as
reported, were interdependent [24]. We therefore dissected
mortality and ICU-LOS and improved the correlation
between SAPS II and LOS. Notably, we found this correl-
ation to be negative in ICU non-survivors, likely because
death reduces the risk for prolonged ICU-LOS. When the
impact of DRG was tested again in this stratified set of data
(Additional file 1: Table S4), SAPS II to ICU-LOS correla-
tions were strongest in 2013. This is consistent with ICU-
LOS which is driven by severity of disease and not logistic
issues in ICU services and speculatively with more efficient
end of life strategies in ICU non-survivors. In other words,
there is some evidence, that Swiss-DRG enforces more
rational, and faster, decisions as to whether to admit a
patient to ICU and a patient’s need to stay in ICU.
Whereas improving efficiency is warranted, effectiveness
(e.g. survival of the patient) is the ultimate goal of health
services. We found mortality to decrease over the study
period (Fig. 3) and Swiss-DRG to possibly coincide with
an improved reduction of the ICU mortality. Our results
confirm previous studies from USA, Australia and New
Zealand, which overall described a significant fall in
mortality over the past years [38, 39]. Similar to our con-
clusions, previous work from the US demonstrated no
negative effects of DRG on mortality [40, 41] in general.
Swiss data in patients with pneumonia [34] further
confirms this conclusion. Whether indeed Swiss-DRG
does not negatively affect ICU mortality remains to be
clarified by additional research, since to our knowledge we
are the first to provide such data.
Several limitations apply. First, the retrospective aspect
of the analysis does not allow a full understanding of the
mechanisms leading to the observed changes in clinical
severity (SAPS II Score) and type (internal, external) of
admission after DRG introduction. Although we as-
sumed that no administrative and financial factors other
than the DRG introduction have occurred, the number
of beds available, the prevalence of epidemics, and ad-
ministrative pressures are not addressed in this study.
Secondly, our data might not be representative since the
months October to December were excluded from the
data analysed, due to structural changes in acute care
provision in October 2013. Third, the data set without
integration of clinical information (Diagnoses, comor-
bidities) excluded explorative analyses allowing for un-
derstanding in the shifts in admission policies. Last, the
analysed period under DRG was short and effects might
only become effective after prolonged time.
Conclusion
To our knowledge, we present a first set of data on how
Swiss-DRG influences our practices in Swiss ICUs. We
believe that the relatively large data set and the design
testing for an additional impact of Swiss-DRG, in an
evolving system, are the primary strength of our analysis.
In contrast, major drawbacks include the retrospective
study design, exclusion of the months October to
December, recruitment from only one single university
hospital centre, and the short time series available due
to structural changes at our institution.
Our data supports minor shifts of patient flow, which
may well be of benefit for referral hospitals. Our data how-
ever support conclusions drawn in other countries where
DRG has not negatively impacted quality in ICU services.
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